{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:00:20Z","timestamp":1787500820556,"version":"build-2736575974"},"reference-count":155,"publisher":"Bentham Science Publishers Ltd.","issue":"20","funder":[{"name":"Cooperation Program of Xiamen Institute of Rare-earth Materials and Xiamen Tasman BIOTECH Co., Ltd","award":["2022350204002401"],"award-info":[{"award-number":["2022350204002401"]}]},{"name":"Cooperation Program of Xiamen Institute of Rare-earth Materials and Xiamen Tasman BIOTECH Co., Ltd","award":["2022350204004248"],"award-info":[{"award-number":["2022350204004248"]}]},{"name":"Science and Technology Planning Program of Xiamen","award":["2022CXY0702"],"award-info":[{"award-number":["2022CXY0702"]}]},{"name":"Science and Technology Planning Program of Xiamen","award":["2023CXY0701"],"award-info":[{"award-number":["2023CXY0701"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Influenza is an acute respiratory disease caused by influenza viruses. It has the\ncharacteristics of fast transmission and strong infectivity, and it does great harm to human\nhealth and survival. It is estimated that the seasonal influenza epidemics every year will\ncause about one billion cases of infections and hundreds of thousands of deaths worldwide,\nwhile influenza A virus is the leading cause of infection and death. Currently, the\nmain drugs used in clinics to treat influenza viruses are neuraminidase inhibitors, and these\ndrugs have shown excellent efficacy in treating influenza viruses. However, various\nmutant strains have developed resistance to these effective drugs in clinics (such as the\nsubtype mutant strains of H274Y in H1N1 or H5N1 and E119V in H3N2 have developed\nresistance to Oseltamivir). Influenza viruses mutate frequently, and new viral strains are\nconstantly discovered, and the pandemics will break out at any time. Therefore, it is urgent\nto develop efficient and broad-spectrum drugs to prevent and treat the influenza pandemic\ncaused by the emerging new subtypes. This review focuses on describing the pandemic\nhistory, the structure, function and prevention methods of influenza viruses and the\nprogress of the development of anti-influenza drugs, to provide the reference for prevention\nand treatment of influenza viruses and development of influenza virus inhibitors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673268314231204061224","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T04:29:56Z","timestamp":1708057796000},"page":"4055-4077","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Progress of Influenza Viruses and Inhibitors"],"prefix":"10.2174","volume":"32","author":[{"given":"Yuchen","family":"Xiao","sequence":"first","affiliation":[{"name":"Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China"},{"name":"University of Chinese Academy of Sciences, Beijing, China"},{"name":"Shanghai Tech University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Yong","sequence":"additional","affiliation":[{"name":"Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China"},{"name":"Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoji","family":"Lu","sequence":"additional","affiliation":[{"name":"Xiamen Tasman BIOTECH Co., Ltd., Fujian Academy of Agricultural Sciences, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canzhong","family":"Lu","sequence":"additional","affiliation":[{"name":"Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, China"},{"name":"University of Chinese Academy of Sciences, Beijing, China"},{"name":"Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwen","family":"Huang","sequence":"additional","affiliation":[{"name":"Xiamen Tasman BIOTECH Co., Ltd., Fujian Academy of Agricultural Sciences, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","volume":"222","author":"Smith W.","year":"1933","unstructured":"Smith W.; Andrewes C.H.; Laidlaw P.P.; A virus obtained from influenza patients. Lancet  1933,222(5732),66-68","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/289366a0","volume":"289","author":"Wilson I.A.","year":"1981","unstructured":"Wilson I.A.; Skehel J.J.; Wiley D.C.; Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 \u00c5 resolution. Nature  1981,289(5796),366-373","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","volume":"303","author":"Colman P.M.","year":"1983","unstructured":"Colman P.M.; Varghese J.N.; Laver W.G.; Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature  1983,303(5912),41-44","journal-title":"Nature"},{"key":"ref=4","year":"2010","unstructured":"History of influenza Pandemics [EB\/OL].  Available from:  http:\/\/www.euro.who.int\/influenza\/20080702-9,2010-09-012010"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","volume":"12","author":"Kilbourne E.D.","year":"2006","unstructured":"Kilbourne E.D.; Influenza pandemics of the 20 century. Emerg Infect Dis  2006,12(1),9-14","journal-title":"Emerg Infect Dis"},{"key":"ref=6","year":"2009","unstructured":"Pandemic(H1N1)2009-update112[EB\/OL]. Available from:  http:\/\/www.who.int\/csr\/don\/2010-08 06\/en\/index.html2009"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","volume":"56","author":"Webster R.G.","year":"1992","unstructured":"Webster R.G.; Bean W.J.; Gorman O.T.; Chambers T.M.; Kawaoka Y.; Evolution and ecology of influenza A viruses. Microbiol Rev  1992,56(1),152-179","journal-title":"Microbiol Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.18388\/abp.2014_1860","volume":"61","author":"Urbaniak K.","year":"2014","unstructured":"Urbaniak K.; Markowska-Daniel I.; In vivo reassortment of influenza viruses. Acta Biochim Pol  2014,61(3),427-431","journal-title":"Acta Biochim Pol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1073\/pnas.73.9.3045","volume":"73","author":"McGeoch D.","year":"1976","unstructured":"McGeoch D.; Fellner P.; Newton C.; Influenza virus genome consists of eight distinct RNA species. Proc Natl Acad Sci  1976,73(9),3045-3049","journal-title":"Proc Natl Acad Sci"},{"key":"ref=10","first-page":"15","author":"Lamb R.A.","year":"2001","unstructured":"Lamb R.A.; Krug R.M.; Orthomyxoviridase: The viruses and their replication. Fields virology  2001,15-32","journal-title":"Fields virology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1073\/pnas.78.7.4133","volume":"78","author":"Maeda T.","year":"1981","unstructured":"Maeda T.; Kawasaki K.; Ohnishi S.; Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. Proc Natl Acad Sci  1981,78(7),4133-4137","journal-title":"Proc Natl Acad Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0042-6822(81)90030-1","volume":"110","author":"Huang R.T.C.","year":"1981","unstructured":"Huang R.T.C.; Rott R.; Klenk H.D.; Influenza viruses cause hemolysis and fusion of cells. Virology  1981,110(1),243-247","journal-title":"Virology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1017\/S0033583500005072","volume":"16","author":"White J.","year":"1983","unstructured":"White J.; Kielian M.; Helenius A.; Membrane fusion proteins of enveloped animal viruses. Q Rev Biophys  1983,16(2),151-195","journal-title":"Q Rev Biophys"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","volume":"109","author":"Tong S.","year":"2012","unstructured":"Tong S.; Li Y.; Rivailler P.; Conrardy C.; Castillo D.A.A.; Chen L.M.; Recuenco S.; Ellison J.A.; Davis C.T.; York I.A.; Turmelle A.S.; Moran D.; Rogers S.; Shi M.; Tao Y.; Weil M.R.; Tang K.; Rowe L.A.; Sammons S.; Xu X.; Frace M.; Lindblade K.A.; Cox N.J.; Anderson L.J.; Rupprecht C.E.; Donis R.O.; A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci  2012,109(11),4269-4274","journal-title":"Proc Natl Acad Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"18635","DOI":"10.1073\/pnas.1215857109","volume":"109","author":"Garc\u00eda-Sastre A.","year":"2012","unstructured":"Garc\u00eda-Sastre A.; The neuraminidase of bat influenza viruses is not a neuraminidase. Proc Natl Acad Sci  2012,109(46),18635-18636","journal-title":"Proc Natl Acad Sci"},{"key":"ref=16","first-page":"213","volume":"31","author":"Cai Y.C.","year":"2009","unstructured":"Cai Y.C.; Huang C.; Ku Z.Q.; Huang Z.; Influenza virus VS influenza vaccine --a Nonstop over the last one hundred years. Chin J Nat  2009,31(4),213-222","journal-title":"Chin J Nat"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1126\/science.1213362","volume":"336","author":"Herfst S.","year":"2012","unstructured":"Herfst S.; Schrauwen E.J.A.; Linster M.; Chutinimitkul S.; de Wit E.; Munster V.J.; Sorrell E.M.; Bestebroer T.M.; Burke D.F.; Smith D.J.; Rimmelzwaan G.F.; Osterhaus A.D.M.E.; Fouchier R.A.M.; Airborne transmission of influenza A\/H5N1 virus between ferrets. Science  2012,336(6088),1534-1541","journal-title":"Science"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/0042-6822(79)90264-2","volume":"93","author":"Scholtissek C.","year":"1979","unstructured":"Scholtissek C.; The genes coding for the surface glycoproteins of influenza A viruses contain a small conserved and a large variable region. Virology  1979,93(2),594-597","journal-title":"Virology"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1073\/pnas.0701396104","volume":"104","author":"Shih A.C.C.","year":"2007","unstructured":"Shih A.C.C.; Hsiao T.C.; Ho M.S.; Li W.H.; Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci  2007,104(15),6283-6288","journal-title":"Proc Natl Acad Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/BF01719674","volume":"10","author":"Scholtissek C.","year":"1994","unstructured":"Scholtissek C.; Source for influenza pandemics. Eur J Epidemiol  1994,10(4),455-458","journal-title":"Eur J Epidemiol"},{"key":"ref=21","first-page":"139","volume":"80","author":"Scholtissek C.","year":"1978","unstructured":"Scholtissek C.; The genome of the influenza virus. Curr Top Microbiol Immunol  1978,80,139-169","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000157337","volume":"2","author":"Scholtissek C.","year":"1990","unstructured":"Scholtissek C.; Pigs as \u2018Mixing Vessels\u2019 for the creation of new pandemic influenza a viruses. Med Princ Pract  1990,2(2),65-71","journal-title":"Med Princ Pract"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1128\/jvi.63.11.4603-4608.1989","volume":"63","author":"Kawaoka Y.","year":"1989","unstructured":"Kawaoka Y.; Krauss S.; Webster R.G.; Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol  1989,63(11),4603-4608","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/infdis\/174.4.838","volume":"174","author":"Lakey D.L.","year":"1996","unstructured":"Lakey D.L.; Treanor J.J.; Betts R.F.; Smith G.E.; Thompson J.; Sannella E.; Reed G.; Wilkinson B.E.; Wright P.F.; Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. J Infect Dis  1996,174(4),838-841","journal-title":"J Infect Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/595861","volume":"199","author":"Belongia E.A.","year":"2009","unstructured":"Belongia E.A.; Kieke B.A.; Donahue J.G.; Greenlee R.T.; Balish A.; Foust A.; Lindstrom S.; Shay D.K.; Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis  2009,199(2),159-167","journal-title":"J Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"105499","DOI":"10.1016\/j.antiviral.2022.105499","volume":"210","author":"Jones J.C.","year":"2023","unstructured":"Jones J.C.; Yen H.L.; Adams P.; Armstrong K.; Govorkova E.A.; Influenza antivirals and their role in pandemic preparedness. Antiviral Res  2023,210,105499","journal-title":"Antiviral Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/13543784.2021.1994944","volume":"30","author":"Hu Y.","year":"2021","unstructured":"Hu Y.; Li H.; Wu M.; Zhang H.; Ding Y.; Peng Y.; Li X.; Yu Z.; Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: A phase 1 double-blind study in healthy subjects. Expert Opin Investig Drugs  2021,30(11),1159-1167","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/jac\/dku074","volume":"69","author":"Ivachtchenko A.V.","year":"2014","unstructured":"Ivachtchenko A.V.; Ivanenkov Y.A.; Mitkin O.D.; Yamanushkin P.M.; Bichko V.V.; Shevkun N.A.; Karapetian R.N.; Leneva I.A.; Borisova O.V.; Veselov M.S.; Veselov M.S.; Novel oral anti-influenza drug candidate AV5080. J Antimicrob Chemother  2014,69(7),1892-1902","journal-title":"J Antimicrob Chemother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.144.3620.862","volume":"144","author":"Davies W.L.","year":"1964","unstructured":"Davies W.L.; Grunert R.R.; Haff R.F.; McGahen J.W.; Neumayer E.M.; Paulshock M.; Watts J.C.; Wood T.R.; Hermann E.C.; Hoffmann C.E.; Antiviral activity of 1-adamantanamine (amantadine). Science  1964,144(3620),862-863","journal-title":"Science"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0092-8674(92)90452-I","volume":"69","author":"Pinto L.H.","year":"1992","unstructured":"Pinto L.H.; Holsinger L.J.; Lamb R.A.; Influenza virus M2 protein has ion channel activity. Cell  1992,69(3),517-528","journal-title":"Cell"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","volume":"366","author":"Bright R.A.","year":"2005","unstructured":"Bright R.A.; Medina M.; Xu X.; Perez-Oronoz G.; Wallis T.R.; Davis X.M.; Povinelli L.; Cox N.J.; Klimov A.I.; Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern. Lancet  2005,366(9492),1175-1181","journal-title":"Lancet"},{"key":"ref=32","first-page":"21","volume":"20","author":"Lan Y.","year":"2006","unstructured":"Lan Y.; Li Z.; Dong L.B.; Zhang Y.; Wen L.Y.; Zhang Y.M.; Wang M.; Guo Y.J.; Shu Y.L.; [Adamantane resistance among influenza A (H3N2) viruses isolated from the mainland of China]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi  2006,20(2),21-23","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"ref=33","first-page":"26","volume":"10","author":"Soo W.","year":"1989","unstructured":"Soo W.; Adverse effects of rimantadine: summary from clinical trials. J Respir Dis  1989,10,26-31","journal-title":"J Respir Dis"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/infdis\/159.3.430","volume":"159","author":"Belshe R.B.","year":"1989","unstructured":"Belshe R.B.; Burk B.; Newman F.; Cerruti R.L.; Sim I.S.; Resistance of influenza A virus to amantadine and rimantadine: Results of one decade of surveillance. J Infect Dis  1989,159(3),430-435","journal-title":"J Infect Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","volume":"33","author":"Palese P.","year":"1976","unstructured":"Palese P.; Compans R.W.; Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of action. J Gen Virol  1976,33(1),159-163","journal-title":"J Gen Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/303035a0","volume":"303","author":"Varghese J.N.","year":"1983","unstructured":"Varghese J.N.; Laver W.G.; Colman P.M.; Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 \u00c5 resolution. Nature  1983,303(5912),35-40","journal-title":"Nature"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/bchm2.1936.240.1-2.43","volume":"240","author":"Blix G.","year":"1936","unstructured":"Blix G.; \u00dcber die Kohlenhydratgruppen des Submaxillarismucins. Hoppe Seylers Z Physiol Chem  1936,240(1-2),43-54","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/BF00903465","volume":"100","author":"Meindl P.","year":"1969","unstructured":"Meindl P.; Tuppy H.; 2-deoxy-2.3-dehydro-sialic acids, I: Synthesis and properties of 2-deoxy-2.3-dehydro-N-acyl-neuraminic acids and their methyl esters. Monatsh Chem  1969,100(4),1295-1306","journal-title":"Monatsh Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1515\/bchm2.1969.350.2.1088","volume":"350","author":"Meindl P.","year":"1969","unstructured":"Meindl P.; Tuppy H.; [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids]. Hoppe Seylers Z Physiol Chem  1969,350(9),1088-1092","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1021\/jm950294c","volume":"39","author":"von Itzstein M.","year":"1996","unstructured":"von Itzstein M.; Dyason J.C.; Oliver S.W.; White H.F.; Wu W.Y.; Kok G.B.; Pegg M.S.; A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs. J Med Chem  1996,39(2),388-391","journal-title":"J Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/jm00145a002","volume":"28","author":"Goodford P.J.","year":"1985","unstructured":"Goodford P.J.; A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem  1985,28(7),849-857","journal-title":"J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/bi0205449","volume":"42","author":"Stoll V.","year":"2003","unstructured":"Stoll V.; Stewart K.D.; Maring C.J.; Muchmore S.; Giranda V.; Gu Y.; Wang G.; Chen Y.; Influenza neuraminidase inhibitors: Structure-based design of a novel inhibitors series. Biochemistry  2003,42(3),718-727","journal-title":"Biochemistry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1006\/jmbi.1993.1461","volume":"232","author":"Bossart-Whitaker P.","year":"1993","unstructured":"Bossart-Whitaker P.; Carson M.; Babu Y.S.; Smith C.D.; Laver W.G.; Air G.M.; Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. J Mol Biol  1993,232(4),1069-1083","journal-title":"J Mol Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm00031a011","volume":"37","author":"Taylor N.R.","year":"1994","unstructured":"Taylor N.R.; von Itzstein M.; Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J Med Chem  1994,37(5),616-624","journal-title":"J Med Chem"},{"key":"ref=45","first-page":"141","volume":"3","author":"Li C.Y.","year":"2001","unstructured":"Li C.Y.; Inhaled Zanamivir to prevent influenza transmission in families. Epidemiology Lemology Foreign Medical Science  2001,3,141-142","journal-title":"Epidemiology Lemology Foreign Medical Science"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00003088-199936001-00003","volume":"36","author":"Cass L.M.R.","year":"1999","unstructured":"Cass L.M.R.; Brown J.; Pickford M.; Fayinka S.; Newman S.P.; Johansson C.J.; Bye A.; Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers. Clin Pharmacokinet  1999,36(S1),21-31","journal-title":"Clin Pharmacokinet"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","volume":"36","author":"Cass L.M.R.","year":"1999","unstructured":"Cass L.M.R.; Efthymiopoulos C.; Bye A.; Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet  1999,36(S1),1-11","journal-title":"Clin Pharmacokinet"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00003088-199936001-00005","volume":"36","author":"Daniel M.J.","year":"1999","unstructured":"Daniel M.J.; Barnett J.M.; Pearson B.A.; The low potential for drug interactions with zanamivir. Clin Pharmacokinet  1999,36(S1),41-50","journal-title":"Clin Pharmacokinet"},{"key":"ref=49","first-page":"3252","volume":"25","author":"Kang H.L.","year":"2011","unstructured":"Kang H.L.; Clinical observation and nursing of patients with influenza using inhaled Zanamivir. Clin Nurs Res  2011,25(35),3252-3253","journal-title":"Clin Nurs Res"},{"key":"ref=50","first-page":"183","author":"Li Z.R.","year":"2001","unstructured":"Li Z.R.; Zanamivir, a new broad-spectrum and highly effective anti-influenza virus drug. World Notes on Antibiotics  2001(04),183-187","journal-title":"World Notes on Antibiotics"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/314440","volume":"178","author":"Gubareva L.V.","year":"1998","unstructured":"Gubareva L.V.; Matrosovich M.N.; Brenner M.K.; Bethell R.C.; Webster R.G.; Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis  1998,178(5),1257-1262","journal-title":"J Infect Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01200-09","volume":"83","author":"Hurt A.C.","year":"2009","unstructured":"Hurt A.C.; Holien J.K.; Parker M.; Kelso A.; Barr I.G.; Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol  2009,83(20),10366-10373","journal-title":"J Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1128\/AAC.42.3.640","volume":"42","author":"Mendel D.B.","year":"1998","unstructured":"Mendel D.B.; Tai C.Y.; Escarpe P.A.; Li W.; Sidwell R.W.; Huffman J.H.; Sweet C.; Jakeman K.J.; Merson J.; Lacy S.A.; Lew W.; Williams M.A.; Zhang L.; Chen M.S.; Bischofberger N.; Kim C.U.; Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection. Antimicrob Agents Chemother  1998,42(3),640-646","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929867003374886","volume":"7","author":"Lew W.","year":"2000","unstructured":"Lew W.; Chen X.; Kim C.U.; Discovery and development of GS 4104 (oseltamivir): An orally active influenza neuraminidase inhibitor. Curr Med Chem  2000,7(6),663-672","journal-title":"Curr Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","volume":"37","author":"He G.","year":"1999","unstructured":"He G.; Massarella J.; Ward P.; Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet  1999,37(6),471-484","journal-title":"Clin Pharmacokinet"},{"key":"ref=56","first-page":"68","volume":"18","author":"Yu J.","year":"2009","unstructured":"Yu J.; Dai D.Y.; Wang X.Y.; Clinical application of two anti-influenza A (H1N1) virus drugs. China Pharmaceuticals  2009,18(16),68-69","journal-title":"China Pharmaceuticals"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3233\/JRS-2011-0545","volume":"23","author":"Hama R.","year":"2011","unstructured":"Hama R.; Jones M.; Okushima H.; Kitao M.; Noda N.; Hayashi K.; Sakaguchi K.; Oseltamivir and early deterioration leading to death: A proportional mortality study for 2009A\/H1N1 influenza. Int J Risk Saf Med  2011,23(4),201-215","journal-title":"Int J Risk Saf Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1001\/jama.2009.297","volume":"301","author":"Gooskens J.","year":"2009","unstructured":"Gooskens J.; Jonges M.; Claas E.C.J.; Meijer A.; van den Broek P.J.; Kroes A.M.; Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA  2009,301(10),1042-1046","journal-title":"JAMA"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/4371108a","volume":"437","author":"Le Q.M.","year":"2005","unstructured":"Le Q.M.; Kiso M.; Someya K.; Sakai Y.T.; Nguyen T.H.; Nguyen K.H.L.; Pham N.D.; Ngyen H.H.; Yamada S.; Muramoto Y.; Horimoto T.; Takada A.; Goto H.; Suzuki T.; Suzuki Y.; Kawaoka Y.; Isolation of drug-resistant H5N1 virus. Nature  2005,437(7062),1108","journal-title":"Nature"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","volume":"283","author":"Treanor J.J.","year":"2000","unstructured":"Treanor J.J.; Hayden F.G.; Vrooman P.S.; Barbarash R.; Bettis R.; Riff D.; Singh S.; Kinnersley N.; Ward P.; Mills R.G.; Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. JAMA  2000,283(8),1016-1024","journal-title":"JAMA"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1021\/jm0002679","volume":"43","author":"Babu Y.S.","year":"2000","unstructured":"Babu Y.S.; Chand P.; Bantia S.; Kotian P.; Dehghani A.; El-Kattan Y.; Lin T.H.; Hutchison T.L.; Elliott A.J.; Parker C.D.; Ananth S.L.; Horn L.L.; Laver G.W.; Montgomery J.A.; BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem  2000,43(19),3482-3486","journal-title":"J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.45.4.1162-1167.2001","volume":"45","author":"Bantia S.","year":"2001","unstructured":"Bantia S.; Parker C.D.; Ananth S.L.; Horn L.L.; Andries K.; Chand P.; Kotian P.L.; Dehghani A.; El-Kattan Y.; Lin T.; Hutchison T.L.; Montgomery J.A.; Kellog D.L.; Babu Y.S.; Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir. Antimicrob Agents Chemother  2001,45(4),1162-1167","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","volume":"69","author":"Bantia S.","year":"2006","unstructured":"Bantia S.; Arnold C.S.; Parker C.D.; Upshaw R.; Chand P.; Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res  2006,69(1),39-45","journal-title":"Antiviral Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/irv.12187","volume":"8","author":"Leang S.K.","year":"2014","unstructured":"Leang S.K.; Kwok S.; Sullivan S.G.; Maurer-Stroh S.; Kelso A.; Barr I.G.; Hurt A.C.; Peramivir and laninamivir susceptibility of circulating influenza A and B viruses. Influenza Other Respir Viruses  2014,8(2),135-139","journal-title":"Influenza Other Respir Viruses"},{"key":"ref=65","first-page":"1964","volume":"19","author":"Zhao X.","year":"2010","unstructured":"Zhao X.; Zhou Y.; Lu M.; Wang L.L.; Li S.; Zhang H.L.; Cui Y.M.; Study on the tolerance of paramivir trihydrate chloride injection in healthy volunteers. Chin J New Drug  2010,19(21),1964-1966","journal-title":"Chin J New Drug"},{"key":"ref=66","first-page":"751","volume":"29","author":"Zhao X.","year":"2013","unstructured":"Zhao X.; Lu M.; Zhang Y.H.; Wang L.L.; Li S.; Zhang H.L.; Gu J.K.; Cui Y.M.; Pharmacokinetics of paramivir trihydrate sodium chloride in healthy volunteers. Chin J Clin Pgarmaclo  2013,29(10),751-754","journal-title":"Chin J Clin Pgarmaclo"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/AAC.00333-08","volume":"53","author":"Yamashita M.","year":"2009","unstructured":"Yamashita M.; Tomozawa T.; Kakuta M.; Tokumitsu A.; Nasu H.; Kubo S.; CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother  2009,53(1),186-192","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/eri.11.112","volume":"9","author":"Ikematsu H.","year":"2011","unstructured":"Ikematsu H.; Kawai N.; Laninamivir octanoate: A new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti Infect Ther  2011,9(10),851-857","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=69","first-page":"93","volume":"5","author":"Yamashita M.","year":"2011","unstructured":"Yamashita M.; Unique characteristics of long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) that explains its long-lasting activity. Influenza Other Respir Viruses  2011,5,93-95","journal-title":"Influenza Other Respir Viruses"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1086\/656802","volume":"51","author":"Watanabe A.","year":"2010","unstructured":"Watanabe A.; Chang S.C.; Kim M.J.; Chu D.W.; Ohashi Y.; Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin Infect Dis  2010,51(10),1167-1175","journal-title":"Clin Infect Dis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1128\/AAC.01755-09","volume":"54","author":"Sugaya N.","year":"2010","unstructured":"Sugaya N.; Ohashi Y.; Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother  2010,54(6),2575-2582","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e1000786","DOI":"10.1371\/journal.ppat.1000786","volume":"6","author":"Kiso M.","year":"2010","unstructured":"Kiso M.; Kubo S.; Ozawa M.; Le Q.M.; Nidom C.A.; Yamashita M.; Kawaoka Y.; Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathog  2010,6(2),e1000786","journal-title":"PLoS Pathog"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1128\/AAC.03313-14","volume":"58","author":"Samson M.","year":"2014","unstructured":"Samson M.; Abed Y.; Desrochers F.M.; Hamilton S.; Luttick A.; Tucker S.P.; Pryor M.J.; Boivin G.; Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir. Antimicrob Agents Chemother  2014,58(9),5220-5228","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"Samson M.","year":"2013","unstructured":"Samson M.; Pizzorno A.; Abed Y.; Boivin G.; Influenza virus resistance to neuraminidase inhibitors. Antiviral Res  2013,98(2),174-185","journal-title":"Antiviral Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3851\/IMP1688","volume":"21","author":"Yamashita M.","year":"2010","unstructured":"Yamashita M.; Laninamivir and its prodrug, CS-8958: Long-acting neuraminidase inhibitors for the treatment of influenza. Antivir Chem Chemother  2010,21(2),71-84","journal-title":"Antivir Chem Chemother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1038\/nmicrobiol.2016.29","volume":"1","author":"te Velthuis A.J.W.","year":"2016","unstructured":"te Velthuis A.J.W.; Robb N.C.; Kapanidis A.N.; Fodor E.; The role of the priming loop in influenza A virus RNA synthesis. Nat Microbiol  2016,1(5),16029","journal-title":"Nat Microbiol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature14009","volume":"516","author":"Reich S.","year":"2014","unstructured":"Reich S.; Guilligay D.; Pflug A.; Malet H.; Berger I.; Cr\u00e9pin T.; Hart D.; Lunardi T.; Nanao M.; Ruigrok R.W.H.; Cusack S.; Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature  2014,516(7531),361-366","journal-title":"Nature"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","volume":"160","author":"Noshi T.","year":"2018","unstructured":"Noshi T.; Kitano M.; Taniguchi K.; Yamamoto A.; Omoto S.; Baba K.; Hashimoto T.; Ishida K.; Kushima Y.; Hattori K.; Kawai M.; Yoshida R.; Kobayashi M.; Yoshinaga T.; Sato A.; Okamatsu M.; Sakoda Y.; Kida H.; Shishido T.; Naito A.; In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antiviral Res  2018,160,109-117","journal-title":"Antiviral Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0166-3542(01)00192-9","volume":"53","author":"Gubareva L.V.","year":"2002","unstructured":"Gubareva L.V.; Webster R.G.; Hayden F.G.; Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res  2002,53(1),47-61","journal-title":"Antiviral Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1128\/AAC.40.1.40","volume":"40","author":"McKimm-Breschkin J.L.","year":"1996","unstructured":"McKimm-Breschkin J.L.; Blick T.J.; Sahasrabudhe A.; Tiong T.; Marshall D.; Hart G.J.; Bethell R.C.; Penn C.R.; Generation and characterization of variants of NWS\/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob Agents Chemother  1996,40(1),40-46","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","volume":"47","author":"McKimmbreschkin J.","year":"2000","unstructured":"McKimmbreschkin J.; Resistance of influenza viruses to neuraminidase inhibitors \u2014 a review. Antiviral Res  2000,47(1),1-17","journal-title":"Antiviral Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.drudis.2012.06.002","volume":"17","author":"Du J.","year":"2012","unstructured":"Du J.; Cross T.A.; Zhou H.X.; Recent progress in structure-based anti-influenza drug design. Drug Discov Today  2012,17(19-20),1111-1120","journal-title":"Drug Discov Today"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/molecules25061375","volume":"25","author":"Lin X.","year":"2020","unstructured":"Lin X.; Li X.; Lin X.; A review on applications of computational methods in drug screening and design. Molecules  2020,25(6),1375","journal-title":"Molecules"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"von Itzstein M.","year":"1993","unstructured":"von Itzstein M.; Wu W.Y.; Kok G.B.; Pegg M.S.; Dyason J.C.; Jin B.; Van Phan T.; Smythe M.L.; White H.F.; Oliver S.W.; Colman P.M.; Varghese J.N.; Ryan D.M.; Woods J.M.; Bethell R.C.; Hotham V.J.; Cameron J.M.; Penn C.R.; Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature  1993,363(6428),418-423","journal-title":"Nature"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1021\/acs.jmedchem.9b02126","volume":"63","author":"Willems H.","year":"2020","unstructured":"Willems H.; De Cesco S.; Svensson F.; Computational chemistry on a budget: Supporting drug discovery with limited resources. J Med Chem  2020,63(18),10158-10169","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.drudis.2016.11.001","volume":"22","author":"Ganesan A.","year":"2017","unstructured":"Ganesan A.; Coote M.L.; Barakat K.; Molecular dynamics-driven drug discovery: Leaping forward with confidence. Drug Discov Today  2017,22(2),249-269","journal-title":"Drug Discov Today"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.antiviral.2013.10.008","volume":"100","author":"Ivachtchenko A.V.","year":"2013","unstructured":"Ivachtchenko A.V.; Ivanenkov Y.A.; Mitkin O.D.; Yamanushkin P.M.; Bichko V.V.; Leneva I.A.; Borisova O.V.; A novel influenza virus neuraminidase inhibitor AV5027. Antiviral Res  2013,100(3),698-708","journal-title":"Antiviral Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jac\/dkt507","volume":"69","author":"Ivachtchenko A.V.","year":"2014","unstructured":"Ivachtchenko A.V.; Ivanenkov Y.A.; Mitkin O.D.; Yamanushkin P.M.; Bichko V.V.; Shevkun N.A.; Mokrushina O.V.; Nevolina O.O.; Karapetian R.N.; Leneva I.A.; Fedyakina I.T.; Veselov M.S.; Novel oral anti-influenza prodrug candidate AV5075S. J Antimicrob Chemother  2014,69(5),1311-1324","journal-title":"J Antimicrob Chemother"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1086\/428839","volume":"40","author":"Fox L.M.","year":"2005","unstructured":"Fox L.M.; Saravolatz L.D.; Nitazoxanide: A new thiazolide antiparasitic agent. Clin Infect Dis  2005,40(8),1173-1180","journal-title":"Clin Infect Dis"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/AAC.03947-14","volume":"59","author":"Belardo G.","year":"2015","unstructured":"Belardo G.; Cenciarelli O.; La Frazia S.; Rossignol J.F.; Santoro M.G.; Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro. Antimicrob Agents Chemother  2015,59(2),1061-1069","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=91","first-page":"63","author":"Guskova T.A.","year":"1999","unstructured":"Guskova T.A.; Glushkov R.G.; Efficacy and safety of arbidol in treating and Prophylaxis of influenza: Clinical trials. Arbidol\u2014A New Antiviral, Immunomodulator, Interferon Inducer (Russian)  1999,63-76","journal-title":"Arbidol\u2014A New Antiviral, Immunomodulator, Interferon Inducer (Russian)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00705-007-0974-5","volume":"152","author":"Shi L.","year":"2007","unstructured":"Shi L.; Xiong H.; He J.; Deng H.; Li Q.; Zhong Q.; Hou W.; Cheng L.; Xiao H.; Yang Z.; Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Arch Virol  2007,152(8),1447-1455","journal-title":"Arch Virol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1128\/AAC.04623-14","volume":"59","author":"Byrn R.A.","year":"2015","unstructured":"Byrn R.A.; Jones S.M.; Bennett H.B.; Bral C.; Clark M.P.; Jacobs M.D.; Kwong A.D.; Ledeboer M.W.; Leeman J.R.; McNeil C.F.; Murcko M.A.; Nezami A.; Perola E.; Rijnbrand R.; Saxena K.; Tsai A.W.; Zhou Y.; Charifson P.S.; Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit. Antimicrob Agents Chemother  2015,59(3),1569-1582","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.02335-12","volume":"57","author":"Lejal N.","year":"2013","unstructured":"Lejal N.; Tarus B.; Bouguyon E.; Chenavas S.; Bertho N.; Delmas B.; Ruigrok R.W.H.; Di Primo C.; Slama-Schwok A.; Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother  2013,57(5),2231-2242","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1080\/07391102.2014.979230","volume":"33","author":"Tarus B.","year":"2015","unstructured":"Tarus B.; Bertrand H.; Zedda G.; Di Primo C.; Quideau S.; Slama-Schwok A.; Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus. J Biomol Struct Dyn  2015,33(9),1899-1912","journal-title":"J Biomol Struct Dyn"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.chest.2016.11.012","volume":"151","author":"Hung I.F.N.","year":"2017","unstructured":"Hung I.F.N.; To K.K.W.; Chan J.F.W.; Cheng V.C.C.; Liu K.S.H.; Tam A.; Chan T.C.; Zhang A.J.; Li P.; Wong T.L.; Zhang R.; Cheung M.K.S.; Leung W.; Lau J.Y.N.; Fok M.; Chen H.; Chan K.H.; Yuen K.Y.; Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: An open-label randomized, controlled, phase IIb\/III trial. Chest  2017,151(5),1069-1080","journal-title":"Chest"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e01432-20","DOI":"10.1128\/JVI.01432-20","volume":"95","author":"Yang F.","year":"2021","unstructured":"Yang F.; Pang B.; Lai K.K.; Cheung N.N.; Dai J.; Zhang W.; Zhang J.; Chan K.H.; Chen H.; Sze K.H.; Zhang H.; Hao Q.; Yang D.; Yuen K.Y.; Kao R.Y.; Discovery of a novel specific inhibitor targeting influenza a virus nucleoprotein with pleiotropic inhibitory effects on various steps of the viral life cycle. J Virol  2021,95(9),e01432-20","journal-title":"J Virol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1021\/acsinfecdis.7b00120","volume":"4","author":"White K.M.","year":"2018","unstructured":"White K.M.; Abreu P.; Wang H.; De Jesus P.D.; Manicassamy B.; Garc\u00eda-Sastre A.; Chanda S.K.; DeVita R.J.; Shaw M.L.; Broad spectrum inhibitor of influenza a and b viruses targeting the viral nucleoprotein. ACS Infect Dis  2018,4(2),146-157","journal-title":"ACS Infect Dis"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"e1005062","DOI":"10.1371\/journal.ppat.1005062","volume":"11","author":"Kakisaka M.","year":"2015","unstructured":"Kakisaka M.; Sasaki Y.; Yamada K.; Kondoh Y.; Hikono H.; Osada H.; Tomii K.; Saito T.; Aida Y.; A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza a virus nucleoprotein. PLoS Pathog  2015,11(7),e1005062","journal-title":"PLoS Pathog"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"21662","DOI":"10.1038\/srep21662","volume":"6","author":"Liu C.L.","year":"2016","unstructured":"Liu C.L.; Hung H.C.; Lo S.C.; Chiang C.H.; Chen I.J.; Hsu J.T.A.; Hou M.H.; Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. Sci Rep  2016,6(1),21662","journal-title":"Sci Rep"},{"key":"ref=101","first-page":"771","volume":"10","author":"Zhang Z.Y.","year":"2015","unstructured":"Zhang Z.Y.; Zhang H.M.; Zhou Z.; Wang S.Q.; Protective effect of Yinqiaosan on H1N1 viral infection in the mice. World J Integr Trad West Med  2015,10(6),771-773","journal-title":"World J Integr Trad West Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.jep.2020.112945","volume":"259","author":"Lee B.W.","year":"2020","unstructured":"Lee B.W.; Ha T.K.Q.; Cho H.M.; An J.P.; Kim S.K.; Kim C.S.; Kim E.; Oh W.K.; Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2. J Ethnopharmacol  2020,259,112945","journal-title":"J Ethnopharmacol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1002\/jmv.26449","volume":"93","author":"Li P.","year":"2021","unstructured":"Li P.; Du R.; Chen Z.; Wang Y.; Zhan P.; Liu X.; Kang D.; Chen Z.; Zhao X.; Wang L.; Rong L.; Cui Q.; Punicalagin is a neuraminidase inhibitor of influenza viruses. J Med Virol  2021,93(6),3465-3472","journal-title":"J Med Virol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1021\/acs.jafc.7b00276","volume":"65","author":"Li R.","year":"2017","unstructured":"Li R.; Liu T.; Liu M.; Chen F.; Liu S.; Yang J.; Anti-influenza a virus activity of dendrobine and its mechanism of action. J Agric Food Chem  2017,65(18),3665-3674","journal-title":"J Agric Food Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"112671","DOI":"10.1016\/j.jep.2020.112671","volume":"253","author":"Zhang T.","year":"2020","unstructured":"Zhang T.; Lo C.Y.; Xiao M.; Cheng L.; Pun Mok C.K.; Shaw P.C.; Anti-influenza virus phytochemicals from radix paeoniae alba and characterization of their neuraminidase inhibitory activities. J Ethnopharmacol  2020,253,112671","journal-title":"J Ethnopharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"115918","DOI":"10.1016\/j.jep.2022.115918","volume":"303","author":"Xiao M.","year":"2023","unstructured":"Xiao M.; Zhang T.; Cao F.; Liang W.; Yang Y.; Huang T.; Tang Y.S.; Liu B.; Zhao X.; Shaw P.C.; Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L. J Ethnopharmacol  2023,303,115918","journal-title":"J Ethnopharmacol"},{"key":"ref=107","first-page":"110","volume":"30","author":"Huang X.J.","year":"2014","unstructured":"Huang X.J.; Wei G.; Zhang G.; Huang K.L.; Research progress on pharmacological action and clinical application of Maxingshigan decoction. Guangdong Yaoxueyuan Xuebao  2014,30(1),110-114","journal-title":"Guangdong Yaoxueyuan Xuebao"},{"key":"ref=108","first-page":"1351","volume":"14","author":"Zhang W.","year":"2007","unstructured":"Zhang W.; Lu F.Y.; He Y.C.; Experimental study on the effect of Maxingshigan decoction on influenza A virus in vitro. Pract Prev Med  2007,14(5),1351-1353","journal-title":"Pract Prev Med"},{"key":"ref=109","first-page":"5","volume":"28","author":"Lu F.Y.","year":"2008","unstructured":"Lu F.Y.; He Y.C.; Xiao Z.Z.; Wu S.R.; Zhang W.; Li S.; Zhou X.; Zhou Y.X.; The action target of Maxingshigan decoction against influenza A virus in vitro. J TCM Univer Hunan  2008,28(2),5-9","journal-title":"J TCM Univer Hunan"},{"key":"ref=110","first-page":"677","volume":"29","author":"He Z.H.","year":"2010","unstructured":"He Z.H.; Zhang J.T.; Sun Y.F.; Therapeutic effect of Qingre decoction on 90 cases of influenza A in children. Shandong J Tradit Chin Med  2010,29(10),677-678","journal-title":"Shandong J Tradit Chin Med"},{"key":"ref=111","first-page":"8","volume":"32","author":"Nan S.L.","year":"2016","unstructured":"Nan S.L.; Xu S.F.; Chen X.; Li F.; Lv M.A.; Li L.; Protective effect of Shengjiang San on the mice infected with influenza virus FM1. PCMM  2016,32(3),8-12","journal-title":"PCMM"},{"key":"ref=112","first-page":"217","volume":"21","author":"Li J.Q.","year":"2003","unstructured":"Li J.Q.; Zhang F.X.; Fu L.C.; Hu X.L.; Zhu Y.T.; Anti-influenza A virus activity and effect on hemagglutination titer of Shengjiangsan (SJS) in vitro. Study J Tradit Chin Med  2003,21(2),217-218","journal-title":"Study J Tradit Chin Med"},{"key":"ref=113","first-page":"28","volume":"18","author":"Li J.Q.","year":"2004","unstructured":"Li J.Q.; Zhang F.X.; Hu X.L.; Fu C.L.; Zhu Y.T.; Experimental study on anti-influenza virus pneumonia of mice by Shengjiangsan (SJS). Pract J Tradit Chin Med  2004,18(1),28-29","journal-title":"Pract J Tradit Chin Med"},{"key":"ref=114","first-page":"38","volume":"2","author":"Li J.H.","year":"2010","unstructured":"Li J.H.; Fu M.; Li Y.L.; Observation and nursing of Lianhua Qingwen Capsule in relieving clinical symptoms of influenza A (H1N1). J Chin Clin Med  2010,2(5),38-39","journal-title":"J Chin Clin Med"},{"key":"ref=115","first-page":"9","volume":"43","author":"Zhang Y.D.","year":"2021","unstructured":"Zhang Y.D.; Shi S.H.; Pan Q.H.; Yang R.P.; Zhao Q.; To study the in vitro test of Radix Pseudostellariae extract against duck influenza virus. J Fujian Husbandy and Vet Med  2021,43(2),9-10","journal-title":"J Fujian Husbandy and Vet Med"},{"key":"ref=116","first-page":"38","year":"2009","unstructured":"Tuorong radix pseudostellariae was selected as a prescription for influenza A. Fujian Agriculture  2009(7),38","journal-title":"Fujian Agriculture"},{"key":"ref=117","first-page":"710","volume":"29","author":"Wang W.","year":"2011","unstructured":"Wang W.; Song L.L.; Song D.G.; Li Q.; Meng Q.G.; Experimental study on the effects of extracts and active components of Scutellaria baicalensis Georgi on Asian influenza A virus. Zhonghua Zhongyiyao Xuekan  2011,29(4),710-712","journal-title":"Zhonghua Zhongyiyao Xuekan"},{"key":"ref=118","first-page":"11","volume":"8","author":"Wang J.J.","year":"2020","unstructured":"Wang J.J.; Li W.P.; Yao H.L.; Qian L.; Ou D.Y.; Therapeutic effect of baicalin on H6N6 avian influenza in mice. Guiyang. J Guizhou Univer  2020,8,11-18","journal-title":"J Guizhou Univer"},{"key":"ref=119","first-page":"757","volume":"30","author":"Liu C.","year":"2021","unstructured":"Liu C.; Cao H.Y.; Liu G.X.; Cheng M.; Xu H.R.; Li M.; Qin X.X.; Guo Y.F.; Zhou H.W.; Li Y.L.; Yu H.Y.; Wang C.X.; Effect of non-toxic dried toad on inflammatory response of mice infected with influenza virus H1N1. J Emerg Tradit Chin Med  2021,30(5),757-761","journal-title":"J Emerg Tradit Chin Med"},{"key":"ref=120","first-page":"47","author":"Cao Y.Q.","year":"2003","unstructured":"Cao Y.Q.; Sun F.; Zhang S.Q.; Liu Z.Y.; Liu J.W.; Experimental study on anti-influenza virus of bufotalin extract. Jilin J Tradit Chin Med  2003(09),47-48","journal-title":"Jilin J Tradit Chin Med"},{"key":"ref=121","first-page":"1","volume":"26","author":"Zhang Z.B.","year":"2003","unstructured":"Zhang Z.B.; Wang Y.Y.; Research on tcm syndrome nomenclature and classification review and hypothesis. Journal of Beijing University of TCM  2003,26(2),1-5","journal-title":"Journal of Beijing University of TCM"},{"key":"ref=122","first-page":"19","volume":"13","author":"Yang H.X.","year":"2007","unstructured":"Yang H.X.; Li X.M.; Effect of extraction of Radix Isatidis on influenza virus. J Tianjin Med Univ  2007,13(1),19-22","journal-title":"J Tianjin Med Univ"},{"key":"ref=123","first-page":"319","volume":"2","author":"Sun K.F.","year":"2010","unstructured":"Sun K.F.; Yu Y.; Zhang Z.; Deng L.; Li C.X.; Yang G.L.; Li L.J.; The antiviral research of water and alcohol extracts of Rhizoma Dryopteris Crassirhizomae. Chinese Pediat Integrat Tradit Western Med  2010,2(04),319-321","journal-title":"Chinese Pediat Integrat Tradit Western Med"},{"key":"ref=124","first-page":"3068","volume":"37","author":"Chen K.T.","year":"2012","unstructured":"Chen K.T.; Zhou W.L.; Liu J.W.; Zu M.; He Z.N.; Du G.H.; Chen W.W.; Liu A.L.; [Active neuraminidase constituents of Polygonum cuspidatum against influenza A(H1N1) influenza virus]. Zhongguo Zhongyao Zazhi  2012,37(20),3068-3073","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=125","first-page":"347","author":"Li W.J.","year":"1999","unstructured":"Li W.J.; Wang S.J.; Yan M.; Observation of the inhibitory effect of extracts from Houttuynia cordata Thunb. on IFVA, IFVB, MPV. Lit and Inf Prev Med  1999(4),347-348","journal-title":"Lit and Inf Prev Med"},{"key":"ref=126","first-page":"615","author":"Guo H.","year":"2003","unstructured":"Guo H.; Yao C.; He S.Q.; Study on resistance of Houttuynia cordata Thunb. to cell apoptosis induced by influenza virus. GMUAJ  2003(6),615-616","journal-title":"GMUAJ"},{"key":"ref=127","first-page":"583","volume":"24","author":"Bao X.T.","year":"2013","unstructured":"Bao X.T.; Guo C.J.; Wang F.; Preliminary research of the flos Lonicerae japonicae on protective effect against mouse\u2019s lung injury induced by influenza virus. Lishizhen Medicine and Materia Medica Research  2013,24(3),583-584","journal-title":"Lishizhen Medicine and Materia Medica Research"},{"key":"ref=128","first-page":"37","author":"Pan Z.Z.","year":"2007","unstructured":"Pan Z.Z.; Wang X.F.; Yan L.J.; Nan C.H.; Yue Z.J.; Inhibitory effect of extracts from flos lonicerae on influenza A virus FM1 strain in vitro. Zhongguo Zhongyiyao Xinxi Zazhi  2007(6),37-38","journal-title":"Zhongguo Zhongyiyao Xinxi Zazhi"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.fitote.2013.12.011","volume":"93","author":"Yang Z.F.","year":"2014","unstructured":"Yang Z.F.; Bai L.P.; Huang W.; Li X.Z.; Zhao S.S.; Zhong N.S.; Jiang Z.H.; Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure\u2013activity relationship analysis. Fitoterapia  2014,93(93),47-53","journal-title":"Fitoterapia"},{"key":"ref=130","first-page":"305","volume":"49","author":"Liu C.","year":"2018","unstructured":"Liu C.; Yan Y.T.; Wang J.; Bao L.; Gao Z.P.; Screening on phloroglucinols of anti-influenza virus activity from Dryopteris crassirhizoma. Chin Tradit Herbal Drugs  2018,49(2),305-312","journal-title":"Chin Tradit Herbal Drugs"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"e19825","DOI":"10.1371\/journal.pone.0019825","volume":"6","author":"Iwai Y.","year":"2011","unstructured":"Iwai Y.; Murakami K.; Gomi Y.; Hashimoto T.; Asakawa Y.; Okuno Y.; Ishikawa T.; Hatakeyama D.; Echigo N.; Kuzuhara T.; Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts. PLoS One  2011,6(5),e19825","journal-title":"PLoS One"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"31500","DOI":"10.1038\/srep31500","volume":"6","author":"Carcelli M.","year":"2016","unstructured":"Carcelli M.; Rogolino D.; Gatti A.; De Luca L.; Sechi M.; Kumar G.; White S.W.; Stevaert A.; Naesens L.; N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes. Sci Rep  2016,6(1),31500","journal-title":"Sci Rep"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.1016\/j.bmcl.2010.09.077","volume":"20","author":"Nguyen P.H.","year":"2010","unstructured":"Nguyen P.H.; Na M.; Dao T.T.; Ndinteh D.T.; Mbafor J.T.; Park J.; Cheong H.; Oh W.K.; New stilbenoid with inhibitory activity on viral neuraminidases from Erythrina addisoniae. Bioorg Med Chem Lett  2010,20(22),6430-6434","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1248\/bpb.18.295","volume":"18","author":"Nagai T.","year":"1995","unstructured":"Nagai T.; Suzuki Y.; Tomimori T.; Yamada H.; Antiviral activity of plant flavonoid, 5,7,4\u2032-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B viruses. Biol Pharm Bull  1995,18(2),295-299","journal-title":"Biol Pharm Bull"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1055\/s-2001-16484","volume":"67","author":"Kim H.","year":"2001","unstructured":"Kim H.; Jeon W.; Ko B.; Flavanone glycosides from Citrus junos and their anti-influenza virus activity. Planta Med  2001,67(6),548-549","journal-title":"Planta Med"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3136\/fstr.9.242","volume":"9","author":"Hayashi K.","year":"2003","unstructured":"Hayashi K.; Mori M.; Knox Y.M.A.T.S.U.T.A.N.I.; Suzutan T.; Ogasawara M.; Yoshida I.; Hosokawa K.; Tsukui A.; Azuma M.; Anti influenza virus activity of a red-fleshed potato anthocyanin. Food Sci Technol Res  2003,9(3),242-244","journal-title":"Food Sci Technol Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/np400817j","volume":"77","author":"Grienke U.","year":"2014","unstructured":"Grienke U.; Braun H.; Seidel N.; Kirchmair J.; Richter M.; Krumbholz A.; von Grafenstein S.; Liedl K.R.; Schmidtke M.; Rollinger J.M.; Computer-guided approach to access the anti-influenza activity of licorice constituents. J Nat Prod  2014,77(3),563-570","journal-title":"J Nat Prod"},{"key":"ref=138","first-page":"2598","volume":"37","author":"Chen M.H.","year":"2022","unstructured":"Chen M.H.; Wang L.Q.; Ma Q.Y.; Yang Y.; Rong R.; Rapid and targeted discovery of neuraminidase inhibitors from Polygonum cuspidatum Sieb. et Zucc. Zhonghua Zhongyiyao Zazhi  2022,37(5),2598-2602","journal-title":"Zhonghua Zhongyiyao Zazhi"},{"key":"ref=139","first-page":"1497","volume":"21","author":"Lang S.","year":"2019","unstructured":"Lang S.; Yan Y.T.; Liu C.; Yang J.; Wang Z.J.; Gao Z.P.; Screening of influenza virus neuraminidase inhibitors from Japanese Flowering Fern Rhizome. Zhongguo Xiandai Zhongyao  2019,21(11),1497-1504","journal-title":"Zhongguo Xiandai Zhongyao"},{"key":"ref=140","first-page":"3594","volume":"45","author":"Cheng D.F.","year":"2018","unstructured":"Cheng D.F.; Wang J.H.; Huang Q.L.; Zhang L.; Liu J.; Xian H.; Effect of sulfated polysaccharide from algae and traditional Chinese medicine compound on inoculation of H9N2 subtype avian influenza virus in chicken embryo. China Animal Husbandry and Veterinary Medicine  2018,45(12),3594-3600","journal-title":"China Animal Husbandry and Veterinary Medicine"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/md14010004","volume":"14","author":"Song L.","year":"2015","unstructured":"Song L.; Chen X.; Liu X.; Zhang F.; Hu L.; Yue Y.; Li K.; Li P.; Characterization and comparison of the structural features, immune-modulatory and anti-avian influenza virus activities conferred by three algal sulfated polysaccharides. Mar Drugs  2015,14(1),4","journal-title":"Mar Drugs"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3181\/00379727-99-24429","volume":"99","author":"Gerber P.","year":"1958","unstructured":"Gerber P.; Dutcher J.D.; Adams E.V.; Sherman J.H.; Protective effect of seaweed extracts for chicken embryos infected with influenza B or mumps virus. Exp Biol Med  1958,99(3),590-593","journal-title":"Exp Biol Med"},{"key":"ref=143","first-page":"631","author":"Xiao M.T.","year":"2003","unstructured":"Xiao M.T.; Yang J.L.; Lin H.Y.; Tang F.X.; Meng C.; Shi X.A.; Guo Y.H.; Extraction of Porphyra haitanensis polysaccharides and its anti-influenza virus activity. J Fuzhou Univ  2003(05),631-635","journal-title":"J Fuzhou Univ"},{"key":"ref=144","first-page":"11","author":"Zhang F.M.","year":"2006","unstructured":"Zhang F.M.; Zhang S.Q.; Sun F.; Liu Z.Y.; Chen X.Q.; Inhibitory effect of lentinan on influenza virus. J Changchun Univ Chin Med  2006(4),11-12","journal-title":"J Changchun Univ Chin Med"},{"key":"ref=145","first-page":"25","volume":"20","author":"Jia W.","year":"2018","unstructured":"Jia W.; Mao S.M.; Zhang P.P.; Yan G.L.; Jin J.; Liu Y.H.; Study on antiviral effect of Lonicera Thumb polysaccharide in vivo. Liaoning Zhongyiyao Daxue Xuebao  2018,20(6),25-27","journal-title":"Liaoning Zhongyiyao Daxue Xuebao"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00705-009-0503-9","volume":"154","author":"Bing F.H.","year":"2009","unstructured":"Bing F.H.; Liu J.; Li Z.; Zhang G.B.; Liao Y.F.; Li J.; Dong C.Y.; Anti-influenza-virus activity of total alkaloids from Commelina communis L. Arch Virol  2009,154(11),1837-1840","journal-title":"Arch Virol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"112550","DOI":"10.1016\/j.jep.2020.112550","volume":"251","author":"Nie L.","year":"2020","unstructured":"Nie L.; Wu Y.; Dai Z.; Ma S.; Antiviral activity of Isatidis Radix derived glucosinolate isomers and their breakdown products against influenza A in vitro\/ovo and mechanism of action. J Ethnopharmacol  2020,251,112550","journal-title":"J Ethnopharmacol"},{"key":"ref=148","first-page":"310","volume":"13","author":"Yong J.","year":"2013","unstructured":"Yong J.; Lu C.; Aisa H.A.; Advances in studies on the rupestonic acid derivatives as anti-influenza agents. Mini Rev Med Chem  2013,13(2),310-315","journal-title":"Mini Rev Med Chem"},{"key":"ref=149","author":"Yong J.P.","year":"2008","unstructured":"Yong J.P.; Synthesis of rupestonic acid derivatives and in vitro inhibition against influenza and herpes simplex viral activities. PhD Thesis, University of Chinese Academy of Sciences: Beijing  2008","journal-title":"PhD Thesis, University of Chinese Academy of Sciences: Beijing"},{"key":"ref=150","author":"Zhao J.Y.","year":"2011","unstructured":"Zhao J.Y.; Study on synthesis and anti-influenza activity of candidate compounds based on rupestonic acid skeleton. PhD Thesis, University of Chinese Academy of Sciences: Beijing  2011","journal-title":"PhD Thesis, University of Chinese Academy of Sciences: Beijing"},{"key":"ref=151","author":"He Y.W.","year":"2013","unstructured":"He Y.W.; Study on the synthesis and bioactivity of rupestonic acid derivatives as potential influenza virus agents based on the click chemistry and fructodiketoyl-guanidines. PhD Thesis, University of Chinese Academy of Sciences: Beijing  2013","journal-title":"PhD Thesis, University of Chinese Academy of Sciences: Beijing"},{"key":"ref=152","author":"Obul M.","year":"2021","unstructured":"Obul M.; Study on the structural modification of 2-methylene and exocyclic alkene of rupestonic acid and anti influenza virus activity of its derivatives. PhD Thesis, University of Chinese Academy of Sciences: Beijing  2021","journal-title":"PhD Thesis, University of Chinese Academy of Sciences: Beijing"},{"key":"ref=153","author":"Chen L.","year":"2022","unstructured":"Chen L.; Synthesis and anti-influenza activity of rupestonic acid derivatives with acyl and triazole. Master Thesis, University of Chinese Academy of Sciences: Beijing  2022","journal-title":"Master Thesis, University of Chinese Academy of Sciences: Beijing"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1039\/c0np00005a","volume":"27","author":"Ge H.","year":"2010","unstructured":"Ge H.; Wang Y.F.; Xu J.; Gu Q.; Liu H.B.; Xiao P.G.; Zhou J.; Liu Y.; Yang Z.; Su H.; Anti-influenza agents from Traditional Chinese Medicine. Nat Prod Rep  2010,27(12),1758-1780","journal-title":"Nat Prod Rep"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ptr.1892","volume":"20","author":"Wang X.","year":"2006","unstructured":"Wang X.; Jia W.; Zhao A.; Wang X.; Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res  2006,20(5),335-341","journal-title":"Phytother Res"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673268314231204061224","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227016\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673268314231204061224","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:44:43Z","timestamp":1753245883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227016\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":155,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673268314231204061224","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}